<div id="readability-page-1"><p>ABLE Financial Group LLC bought a new stake in  CVS Health Corporation (NYSE:CVS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The fund bought 41,227 shares of the pharmacy operator's stock, valued at approximately $3,108,000.</p><ul><li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li></ul><p>Other institutional investors and hedge funds have also made changes to their positions in the company. Avion Wealth increased its position in  CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator's stock worth $26,000 after buying an additional 189 shares during the period.  Harbor Asset Planning Inc. acquired a new stake in shares of  CVS Health in the 2nd quarter worth about $30,000.  Bell Investment Advisors Inc lifted its position in  CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares during the last quarter.  Front Row Advisors LLC grew its position in  CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 371 shares during the last quarter.  Finally, Roxbury Financial LLC increased its stake in shares of  CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 202 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Analyst Ratings Changes</h2><p>A number of brokerages recently issued reports on CVS. The Goldman Sachs Group increased their price objective on CVS Health from $93.00 to $95.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, December 10th. Truist Financial  set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Wolfe Research lifted their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an &#34;outperform&#34; rating in a research note on Monday, December 8th. Jefferies Financial Group upped their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Finally, Zacks Research cut shares of CVS Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned  a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $94.67.</p><ul><li>MarketBeat Week in Review – 05/12 - 05/16</li></ul><p><b>Check Out Our Latest Stock Analysis on CVS</b></p><h2>CVS Health Stock Performance</h2><p>Shares of CVS opened at $77.70 on Friday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The stock has a market capitalization of $98.63 billion, a P/E ratio of 204.47, a P/E/G ratio of 0.77 and a beta of 0.48. The firm's 50 day moving average is $79.09 and its 200-day moving average is $72.43. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. </p><ul><li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li></ul><p>CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts' expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS.  Equities research analysts anticipate that  CVS Health Corporation will post 5.89 EPS for the current fiscal year. </p><h2>CVS Health Profile</h2> (Free Report)<p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.  </p><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than CVS Health</li><li>Mastering Discipline: Overcoming Emotional Challenges In Trading</li><li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li><li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li><li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li><li>How to Calculate Return on Investment (ROI)</li><li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in CVS Health Right Now?</h2><p>Before you consider CVS Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>ABLE Financial Group LLC acquired 41,227 shares of CVS Health Corporation, valued at approximately $3,108,000, in the third quarter. This transaction was reported in their latest 13F filing with the SEC. CVS Health's stock is largely held by institutional investors, with 80.66% ownership. Analysts have given the stock a consensus rating of 'Moderate Buy' with a price target of $94.67. CVS Health reported strong earnings, with a revenue increase of 7.8% year-over-year, and set its FY 2025 EPS guidance at 6.550-6.650.</p>

41,227 Shares in CVS Health Corporation $CVS Purchased by ABLE Financial Group LLC